Aluda Pharmaceuticals
PrivateLast Round
Accelerator
Aug 1, 2023
Company Overview
Aluda Pharmaceuticals is a biopharmaceutical company that develops research and drug-discovery technology focused on immune and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aluda Pharmaceuticals Comparables
Compare Aluda Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Endeavor BioMedicines | 77% | |
| Odyssey Therapeutics | 76% | |
| Galecto Biotech | 73% | |
Aluda Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 1, 2023 |
Aluda Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| California Life Sciences | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 137% MoM, reaching 3.8K.
- Nov 9, 2025
Monthly visitors increased 43% MoM, from 972 to 1.4K.
Aluda Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aluda Pharmaceuticals's valuation, stock price, and market status.